EUVIMEDObjevte EUVIMED
Crossref

Antimicrobial effect of pimozide by targeting ROS‐mediated killing in Staphylococcus aureus

Siddhartha Kumar, Kumar Sandeep, Rakesh Kumar, Antresh Kumar iD

Biotechnology and Applied Biochemistry · 2023

DOI: 10.1002/bab.2465 ↗

At a glance

Journal article in Biotechnology and Applied Biochemistry, 2023. Written by Siddhartha Kumar and 3 co-authors. Institution: Department of Biotechnology, Central University of South Bihar, Gaya, Bihar, India. Major MEDLINE topics: Methicillin-Resistant Staphylococcus aureus, Staphylococcal Infections, Anti-Infective Agents. Cited 9 times so far (Crossref); 48 references.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

In spite of the higher nosocomial and community‐acquired infections caused by Staphylococcus aureus , emerging drug resistance is a leading cause of increased mortality and morbidity associated with the overuse of antimicrobials. It is an emergent need to find out new molecules to combat such infections. In the present study, we analyzed the antibacterial effect of pimozide (PMZ) against gram‐positive and gram‐negative bacterial strains, including methicillin‐sensitive (MSSA) and methicillin‐resistant (MRSA) S. aureus . The growth of MSSA and MRSA was completely inhibited at concentrations of 12.5 and 100 μg/mL, respectively, which is referred to as 1× minimum inhibitory concentration (MIC). The cell viability was completely eliminated within 90 min of PMZ treatment (2× MIC) through reactive oxygen species (ROS)‐mediated killing without affecting cell membrane permeability. It suppressed α‐hemolysin production and biofilm formation of different S. aureus strains by almost 50% at 1× MIC concentration, and was found to detach matured biofilm. PMZ treatment effectively eliminates S. aureus infection in Caenorhabditis elegans and improves its survival by 90% and is found safe to use with no hemolytic effect on human and chicken blood tissues. Taken together, it is concluded that PMZ may turn out to be an effective antibacterial for treating bacterial infections including MSSA and MRSA.

Subjects

MeSH terms (MEDLINE)

Methicillin-Resistant Staphylococcus aureusStaphylococcal InfectionsAnti-Infective AgentsHumansStaphylococcus aureusPimozideReactive Oxygen SpeciesAnti-Bacterial AgentsMethicillinMicrobial Sensitivity Tests

Author keywords

Caenorhabditis elegansROSStaphylococcus aureusantibacterial activitybiofilm inhibitiondrug repurposingpimozide

Substances

PimozideReactive Oxygen SpeciesAnti-Bacterial AgentsMethicillinAnti-Infective Agents

Authors and institutions

  • Department of Biotechnology, Central University of South Bihar, Gaya, Bihar, India.
  • Dr. B.R. Ambedkar Institute - Rotary Cancer Hospital, AIIMS, New Delhi, India.
  • Department of Biochemistry, Central University of Haryana, Mahendergarh, Haryana, India.

ORCID profiles: Antresh Kumar

Cite

APA

Kumar, S., Sandeep, K., Kumar, R., & Kumar, A. (2023). Antimicrobial effect of pimozide by targeting ROS‐mediated killing in Staphylococcus aureus. Biotechnology and Applied Biochemistry. https://doi.org/10.1002/bab.2465

Vancouver

Kumar S, Sandeep K, Kumar R, Kumar A. Antimicrobial effect of pimozide by targeting ROS‐mediated killing in Staphylococcus aureus. Biotechnology and Applied Biochemistry. 2023. doi:10.1002/bab.2465

BibTeX
@article{Kumar2023,
  author = {Kumar, Siddhartha and Sandeep, Kumar and Kumar, Rakesh and Kumar, Antresh},
  title = {Antimicrobial effect of pimozide by targeting ROS‐mediated killing in Staphylococcus aureus},
  journal = {Biotechnology and Applied Biochemistry},
  year = {2023},
  doi = {10.1002/bab.2465}
}
Start for free →